References
Bruijn JA, Moleman P, Mulder PGH, van den Broek WW, van Hülst AM, van der Mast RC, van de Wetering BJM (1996) A double-blind, fixed blood-level study comparing mirtazapine with imipramine in depressed in-patients. Psychopharmacology 127:231–237
Burke MJ, Preskorn SH (1995) Short-term treatment of mood disorders with standard antidepressants. In: Bloom FE, Kupfer DJ (eds) Psychopharmacology. The fourth generation of progress. Raven Press, New York, pp 1053–1065
Davies R, Wilde MI (1996) Mirtazapine. A review of its pharmacology and therapeutic potential in the management of major depression. CNS Drugs 5:389–402
Johnson A, Hold DW (1995) Concentration-controlled trails: what does the future hold? Clin Pharmacokinet 28:93–99
Moleman P, Bruijn JA, Tulen JHM (1996) Het nut van bepaling van bloedspiegels van antidepressiva in de klinische praktijk. Tijdschrift voor Psychiatrie 38:16–29
Preskorn SH (1989) Tricyclic antidepressants: the whys and hows of therapeutic drug monitoring. J Clin Psychiatry 50 [7, Suppl]: 34–42
Preskorn SH, Mac DS (1984) The implication of concentration/response studies of tricyclic antidepressants for psychiatric research and practice. Psychiatr Dev 3:201–222
Sanathanan LP, Peck CC (1991) The randomized concentration-controlled trial: an evaluation of its sample size efficiency. Controlled Clinical Trials 12:780–794
Vestergaard P, Gram LF, Kragh-Sørensen P, Bech P, Reisby, Bolwig TG and the Danish University Antidepressant Group (1993) Therapeutic potentials of recently introduced antidepressants. Psychopharmacology Ser 10:190–198
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pinder, R.M., Zivkov, M. Imipramine and mirtazapine are less effective than expected. Psychopharmacology 129, 297–298 (1997). https://doi.org/10.1007/s002130050195
Received:
Issue Date:
DOI: https://doi.org/10.1007/s002130050195